Reuters logo
BRIEF-Opiant Pharmaceuticals announces appointment of David O’Toole as CFO
September 5, 2017 / 11:22 AM / 2 months ago

BRIEF-Opiant Pharmaceuticals announces appointment of David O’Toole as CFO

Sept 5 (Reuters) - Opiant Pharmaceuticals Inc:

* Opiant Pharmaceuticals Inc announces appointment of David O’Toole as chief financial officer

* Opiant Pharmaceuticals says David O‘Toole will succeed Kevin Pollack, co’s outgoing CFO, who will be stepping down on September 11, 2017​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below